Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 260
Filtrar
Más filtros

Intervalo de año de publicación
1.
Phys Rev Lett ; 118(20): 207202, 2017 May 19.
Artículo en Inglés | MEDLINE | ID: mdl-28581789

RESUMEN

Entanglement of spin and orbital degrees of freedom drives the formation of novel quantum and topological physical states. Here we report resonant inelastic x-ray scattering measurements of the transition metal oxides Ca_{3}LiOsO_{6} and Ba_{2}YOsO_{6}, which reveals a dramatic spitting of the t_{2g} manifold. We invoke an intermediate coupling approach that incorporates both spin-orbit coupling and electron-electron interactions on an even footing and reveal that the ground state of 5d^{3}-based compounds, which has remained elusive in previously applied models, is a novel spin-orbit entangled J=3/2 electronic ground state. This work reveals the hidden diversity of spin-orbit controlled ground states in 5d systems and introduces a new arena in the search for spin-orbit controlled phases of matter.

2.
N Engl J Med ; 362(5): 427-39, 2010 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-20089951

RESUMEN

BACKGROUND: Most persons who are infected with human immunodeficiency virus type 1 (HIV-1) are also infected with herpes simplex virus type 2 (HSV-2), which is frequently reactivated and is associated with increased plasma and genital levels of HIV-1. Therapy to suppress HSV-2 reduces the frequency of reactivation of HSV-2 as well as HIV-1 levels, suggesting that suppression of HSV-2 may reduce the risk of transmission of HIV-1. METHODS: We conducted a randomized, placebo-controlled trial of suppressive therapy for HSV-2 (acyclovir at a dose of 400 mg orally twice daily) in couples in which only one of the partners was seropositive for HIV-1 (CD4 count, > or = 250 cells per cubic millimeter) and that partner was also infected with HSV-2 and was not taking antiretroviral therapy at the time of enrollment. The primary end point was transmission of HIV-1 to the partner who was not initially infected with HIV-1; linkage of transmissions was assessed by means of genetic sequencing of viruses. RESULTS: A total of 3408 couples were enrolled at 14 sites in Africa. Of the partners who were infected with HIV-1, 68% were women, and the baseline median CD4 count was 462 cells per cubic millimeter. Of 132 HIV-1 seroconversions that occurred after randomization (an incidence of 2.7 per 100 person-years), 84 were linked within couples by viral sequencing: 41 in the acyclovir group and 43 in the placebo group (hazard ratio with acyclovir, 0.92, 95% confidence interval [CI], 0.60 to 1.41; P=0.69). Suppression with acyclovir reduced the mean plasma concentration of HIV-1 by 0.25 log(10) copies per milliliter (95% CI, 0.22 to 0.29; P<0.001) and the occurrence of HSV-2-positive genital ulcers by 73% (risk ratio, 0.27; 95% CI, 0.20 to 0.36; P<0.001). A total of 92% of the partners infected with HIV-1 and 84% of the partners not infected with HIV-1 remained in the study for 24 months. The level of adherence to the dispensed study drug was 96%. No serious adverse events related to acyclovir were observed. CONCLUSIONS: Daily acyclovir therapy did not reduce the risk of transmission of HIV-1, despite a reduction in plasma HIV-1 RNA of 0.25 log(10) copies per milliliter and a 73% reduction in the occurrence of genital ulcers due to HSV-2. (ClinicalTrials.gov number, NCT00194519.)


Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Aciclovir/uso terapéutico , Antivirales/uso terapéutico , Infecciones por VIH/transmisión , VIH-1 , Herpes Genital/tratamiento farmacológico , Herpesvirus Humano 2 , Aciclovir/efectos adversos , Adolescente , Adulto , Antivirales/efectos adversos , Recuento de Linfocito CD4 , Femenino , Estudios de Seguimiento , Infecciones por VIH/complicaciones , VIH-1/genética , VIH-1/aislamiento & purificación , Herpes Genital/complicaciones , Humanos , Análisis de Intención de Tratar , Estimación de Kaplan-Meier , Masculino , Cooperación del Paciente , Embarazo , ARN Viral/sangre , Sexo Inseguro/estadística & datos numéricos , Adulto Joven
3.
J Viral Hepat ; 18(10): e447-52, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21914062

RESUMEN

Widespread use of lamivudine in antiretroviral therapy may lead to hepatitis B virus resistance in HIV-HBV coinfected patients from endemic settings where tenofovir is not readily available. We evaluated 389 Kenyan HIV-infected adults before and for 18 months after starting highly active antiretroviral therapy with stavudine, lamivudine and nevirapine. Twenty-seven (6.9%) were HBsAg positive and anti-HBs negative, 24 were HBeAg negative, and 18 had HBV DNA levels ≤ 10,000 IU/mL. Sustained HBV suppression to <100 IU/mL occurred in 89% of 19 evaluable patients. Resistance occurred in only two subjects, both with high baseline HBV DNA levels. Lamivudine resistance can emerge in the setting of incomplete HBV suppression but was infrequently observed among HIV-HBV coinfected patients with low baseline HBV DNA levels.


Asunto(s)
Fármacos Anti-VIH/administración & dosificación , Farmacorresistencia Viral , Infecciones por VIH/tratamiento farmacológico , Virus de la Hepatitis B/efectos de los fármacos , Hepatitis B/tratamiento farmacológico , Lamivudine/administración & dosificación , Adulto , Terapia Antirretroviral Altamente Activa/métodos , ADN Viral/sangre , Femenino , Infecciones por VIH/complicaciones , Hepatitis B/complicaciones , Hepatitis B/virología , Anticuerpos contra la Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/sangre , Virus de la Hepatitis B/aislamiento & purificación , Humanos , Kenia , Masculino , Nevirapina/administración & dosificación , Estavudina/administración & dosificación , Resultado del Tratamiento , Carga Viral
4.
Pain Med ; 12(1): 154-64, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21087405

RESUMEN

OBJECTIVE: To compare fear of movement between obese and non-obese individuals seeking therapy for chronic low back pain and to examine whether fear of movement predicted disability due to back pain, self-reported walking disability, and flexibility. DESIGN: This was a cross-sectional study. SETTING: Outpatient physical therapy clinic associated with a tertiary care hospital. PATIENTS: Patients with chronic low back pain (N=192; 48.2±18.8 years) were stratified into obese (average body mass index [BMI] 36.9±7.1 kg/m(2) ) or non-obese status (average BMI 24.5±3.4 kg/m(2) ). OUTCOME MEASURES: The Tampa Scale of Kinesiophobia (TSK), Short-Form 8 (SF-8), and Oswestry Disability Survey results were main outcome measures. METHODS: Retrospective review of medical charts was performed. Hierarchical regression modeling determined the contribution of TSK scores to the variance of self-reported disability with walking, overall Oswestry score, and flexibility. RESULTS: TSK scores were higher in obese than non-obese patients (26.2±7.5 vs 23.9±6.8 points; P=0.032). The SF-8 physical and mental subscores were 6-10% lower in the obese than non-obese patients. Oswestry survey scores were higher in the obese patients (40.6 vs 31.6 points; P<0.001). TSK scores contributed to self-reported disability with walking and Oswestry disability score (both P<0.001), but not flexibility. CONCLUSIONS: Among obese patients with chronic lumbar pain, pain-related fear of movement enhanced prediction of self-reported disability with walking and overall Oswestry scores. The TSK might be a useful clinical assessment to identify obese patients at higher risk for future low back disability.


Asunto(s)
Dolor de Espalda/psicología , Miedo/psicología , Movimiento/fisiología , Obesidad/psicología , Calidad de Vida/psicología , Adulto , Anciano , Dolor de Espalda/complicaciones , Estudios Transversales , Recolección de Datos , Evaluación de la Discapacidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Valor Predictivo de las Pruebas , Análisis de Regresión , Estudios Retrospectivos , Resultado del Tratamiento , Caminata/fisiología
5.
Disabil Rehabil ; 32(3): 207-15, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20001826

RESUMEN

PURPOSE: To examine the effects of anemia on inpatient rehabilitation outcomes following unilateral and bilateral total knee arthroplasty (TKA). METHOD: This was a multicenter, retrospective study from 15 inpatient rehabilitation facilities. Patients (N = 5421) with very low hematocrit (Hct <30%), low Hct (30-36% women, 30-41% men), or normal Hct (>36% women, 41% men) were included. Inpatient rehabilitation occurred following TKA. Functional independence measure (FIM) scores, length of stay (LOS), itemized hospital charges, discharge destination were main outcomes. RESULTS: LOS was 13% longer and hospital charges were 12.5-18.0% higher in the very low Hct than remaining groups (p = 0.0001). The FIM score and subscores for walking, stair climbing, bathing, transfers, and dressing changes were comparable for all Hct groups for the overall score. Hct <30% did not correspond to worse outcomes in patients with bilateral surgeries compared with unilateral surgeries; total FIM scores improved 47-53% across all Hct groups, regardless of bilateral surgical status. Discharge to home ranged 92.6-94.7% across all Hct groups (p > 0.05). CONCLUSIONS: Rehabilitation teams can expect comparable functional improvements and discharge to home in anemic and non-anemic patients with either unilateral or bilateral surgeries without hematologic correction in the rehabilitation setting, but might need an additional day to accomplish these outcomes.


Asunto(s)
Anemia/complicaciones , Artroplastia de Reemplazo de Rodilla/rehabilitación , Actividades Cotidianas , Anciano , Análisis de Varianza , Distribución de Chi-Cuadrado , Comorbilidad , Femenino , Precios de Hospital , Humanos , Tiempo de Internación/estadística & datos numéricos , Masculino , Recuperación de la Función , Estudios Retrospectivos , Resultado del Tratamiento
6.
Sex Transm Infect ; 85(2): 92-6, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18955387

RESUMEN

BACKGROUND: In certain parts of Africa, type-specific herpes simplex virus type 2 (HSV-2) ELISAs may have limited specificity. To date, no study has been conducted to validate HerpeSelect and Kalon type-specific HSV-2 ELISAs using both the Western blot and recombinant gG ELISA inhibition testing as reference standards. METHODS: A total of 120 men who were HIV seronegative (aged 18-24 years) provided blood samples. HSV-2 IgG serum antibodies were detected using four different methods: HerpeSelect HSV-2 ELISA (n = 120), Kalon HSV-2 ELISA (n = 120), University of Washington Western blot (n = 101) and a recombinant inhibition test (n = 93). RESULTS: HSV-2 seroprevalence differed significantly by HSV-2 detection method, ranging from 24.8% with the Western blot to 69.8% with the HerpeSelect ELISA. Using the Western blot as the reference standard, the HerpesSelect had the highest sensitivity for HSV-2 antibody detection (100%) yet lowest specificity (40%). Similar results were obtained using the inhibition test as the reference standard. The sensitivity and specificity of the Kalon test versus the Western blot were 92% and 79%, respectively, and 80% and 82% versus the inhibition test. Using the inhibition test as the reference standard, the sensitivity of the Western blot appeared low (49%). CONCLUSIONS: In men in western Kenya who were HIV seronegative, the HerpeSelect and Kalon type-specific ELISAs had high sensitivities yet limited specificities using the Western blot as reference standard. Overall, the Kalon ELISA performed better than the HerpeSelect ELISA in these young men from Kisumu. Further understanding is needed for the interpretation of HSV-2 inhibition or ELISA test positive/ Western blot seronegative results. Before HSV-2 seropositivity may be reliably reported in selected areas of Africa, performance studies of HSV-2 serological assays in individual geographical areas are recommended.


Asunto(s)
Anticuerpos Antivirales/sangre , Herpes Genital/virología , Herpesvirus Humano 2/inmunología , Adolescente , Adulto , Western Blotting/métodos , Circuncisión Masculina , Ensayo de Inmunoadsorción Enzimática/métodos , Seronegatividad para VIH , Herpesvirus Humano 2/aislamiento & purificación , Humanos , Inmunoglobulina G/sangre , Kenia , Masculino , Ensayos Clínicos Controlados Aleatorios como Asunto , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Pruebas Serológicas/métodos , Adulto Joven
7.
Int J Adolesc Med Health ; 21(4): 519-29, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-20306764

RESUMEN

UNLABELLED: College students continue to report being disrupted by other students' alcohol use. OBJECTIVE: This study was designed to develop measures to document the consequences resulting from other students' drinking and identify differences in experiencing these consequences by student characteristics and drinking behaviors. STUDY GROUP: A stratified random sample of undergraduate students (N = 3,908) from ten universities in North Carolina, USA, completed a web-based assessment. METHODS: Exploratory factor analysis (EFA) was performed on the random first split-half sample (n = 1,954) to identify factor structure. Confirmatory factor analysis (CFA) was performed on the remaining half sample (n = 1,954) using structural equation modeling. RESULTS: EFA revealed two inventories: interpersonal and community consequences of others' drinking inventories. CFA on the second split-half sample identified model fits for the two factor structure suggested by EFA. Of 3,908 participants, 78% reported experiencing one or more consequences due to others' drinking during the past 30 days. Multivariable generalized linear mixed modeling further validated the inventories and resulted in several associations. Male students who reported getting drunk experienced significantly more interpersonal consequences from others' drinking (p < .001). Minority students, students who lived on campus and students who reported getting drunk experienced significantly more community consequences from others' drinking (p < .01). CONCLUSIONS: These findings demonstrate that 4 out of 5 college students experience consequences from others' drinking, and consequences vary for different subgroups of students. Although these inventories should be tested further, these findings propose standardized measures that may be useful to assess the consequences of others' drinking among college students.


Asunto(s)
Intoxicación Alcohólica/psicología , Asunción de Riesgos , Estudiantes/psicología , Universidades , Intoxicación Alcohólica/etnología , Estudios Transversales , Análisis Factorial , Femenino , Humanos , Masculino , Grupos Minoritarios/psicología , Características de la Residencia , Factores Sexuales , Medio Social
8.
Sex Transm Infect ; 84(2): 140-2, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18096647

RESUMEN

OBJECTIVES: To determine the prevalence and correlates of herpes simplex virus type 2 (HSV-2) seropositivity among fishermen along the shores of Lake Victoria in Kisumu district, Kenya. METHODS: Sera from a random sample of 250 fishermen from 18 beaches were collected after a detailed sociodemographic interview. HSV-2 infection was tested by Kalon HSV-2 ELISA. RESULTS: The HSV-2 seroprevalence was 63.9%. In multivariate analysis, fishermen were more likely to be infected with HSV-2 if they were HIV positive (prevalence ratio (PR) 1.27; 95% CI 1.06 to 1.52) compared with those testing HIV negative, were aged 18-20 (PR 0.49; 95% CI 0.24 to 0.99) and older than 40 (PR 1.66; 95% CI 1.30 to 2.14) years compared with those aged 21-25 years, perceived their last two sexual partners to have a sexually transmitted infection (STI; PR 1.27; 95% CI 1.06 to 1.52) compared with those who did not and were more likely to be circumcised (PR 1.49; 95% CI 1.19 to 1.86). CONCLUSIONS: HSV-2 seroprevalence is high among this population and is associated with HIV serostatus, age, perception about partner's STI status and circumcision.


Asunto(s)
Explotaciones Pesqueras/estadística & datos numéricos , Herpes Genital/epidemiología , Herpesvirus Humano 2/inmunología , Sexo Inseguro/estadística & datos numéricos , Adolescente , Adulto , Anciano , Ensayo de Inmunoadsorción Enzimática , Herpes Genital/virología , Humanos , Kenia/epidemiología , Persona de Mediana Edad , Estudios Seroepidemiológicos , Parejas Sexuales
9.
Regul Pept ; 148(1-3): 33-8, 2008 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-18455814

RESUMEN

Chemotherapy treatment can lead to delayed gastric emptying, early satiety, anorexia, nausea and vomiting, described collectively as the cancer-associated dyspepsia syndrome (CADS). Administration of ghrelin (GHRL), an endogenous orexigenic peptide known to stimulate gastric motility, has been shown to reduce the symptoms of CADS induced in relevant animal models with the potent chemotherapeutic agent, cisplatin. We examined the effects in the rat of cisplatin (6 mg/kg i.p.) treatment on the expression of GHRL and ghrelin receptor (GHSR) mRNAs in the hypothalamus and the stomach at a time-point (2 days) when the effects of cisplatin are pronounced. In addition, plasma levels of GHRL (acylated and total including des-acyl GHRL) were measured and the effect on these levels of treatment with the synthetic glucocorticoid dexamethasone (2 mg/kg s.c. bd.) was investigated. Cisplatin increased GHSR mRNA expression in the stomach (67%) and hypothalamus (52%) but not GHRL mRNA expression and increased the percentage of acylated GHRL (7.03+/-1.35% vs. 11.38+/-2.40%) in the plasma. Dexamethasone reduced the plasma level of acylated GHRL and the percentage of acylated GHRL to values below those in animals treated with saline alone (7.03+/-1.35% vs. 2.60+/-0.49%). Our findings support the hypothesis that an adaptive upregulation of the ghrelin receptor may occur during cancer chemotherapy-associated dyspepsia. This may have a role in defensive responses to toxic challenges to the gut. In addition, our results provide preliminary evidence for glucocorticoid modulation of plasma ghrelin levels.


Asunto(s)
Mucosa Gástrica/metabolismo , Ghrelina/sangre , Hipotálamo/metabolismo , Receptores de Ghrelina/genética , Animales , Antineoplásicos/administración & dosificación , Antineoplásicos/efectos adversos , Peso Corporal/efectos de los fármacos , Cisplatino/administración & dosificación , Cisplatino/efectos adversos , Dexametasona/farmacología , Dispepsia/sangre , Dispepsia/inducido químicamente , Dispepsia/genética , Ingestión de Alimentos/efectos de los fármacos , Ensayo de Inmunoadsorción Enzimática , Vaciamiento Gástrico/efectos de los fármacos , Glucocorticoides/farmacología , Hipotálamo/efectos de los fármacos , Inyecciones Intraperitoneales , Masculino , Neoplasias/tratamiento farmacológico , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Estómago/efectos de los fármacos , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/genética
10.
Am J Health Behav ; 32(4): 411-9, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18092901

RESUMEN

OBJECTIVES: To determine whether drink specials independently increase patrons' risk of achieving a high level of intoxication upon exiting drinking establishments. METHODS: In a campus community, data were collected from exiting patrons (N=291) via sidewalk interviews and breath tests on 6 nights of 2 consecutive semesters. RESULTS: A multivariate model revealed that taking advantage of a drink special was associated with a fourfold increase in risk of achieving a BAC >or= 80 mg/dl. CONCLUSIONS: These findings are the first to document that the drink discounting practices of college bars can be linked to higher intoxication levels among exiting patrons.


Asunto(s)
Consumo de Bebidas Alcohólicas/epidemiología , Intoxicación/diagnóstico , Restaurantes , Universidades , Adulto , Pruebas Respiratorias , Femenino , Humanos , Entrevistas como Asunto , Masculino
11.
N Engl J Med ; 350(1): 11-20, 2004 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-14702423

RESUMEN

BACKGROUND: Nucleoside analogues against herpes simplex virus (HSV) have been shown to suppress shedding of HSV type 2 (HSV-2) on genital mucosal surfaces and may prevent sexual transmission of HSV. METHODS: We followed 1484 immunocompetent, heterosexual, monogamous couples: one with clinically symptomatic genital HSV-2 and one susceptible to HSV-2. The partners with HSV-2 infection were randomly assigned to receive either 500 mg of valacyclovir once daily or placebo for eight months. The susceptible partner was evaluated monthly for clinical signs and symptoms of genital herpes. Source partners were followed for recurrences of genital herpes; 89 were enrolled in a substudy of HSV-2 mucosal shedding. Both partners were counseled on safer sex and were offered condoms at each visit. The predefined primary end point was the reduction in transmission of symptomatic genital herpes. RESULTS: Clinically symptomatic HSV-2 infection developed in 4 of 743 susceptible partners who were given valacyclovir, as compared with 16 of 741 who were given placebo (hazard ratio, 0.25; 95 percent confidence interval, 0.08 to 0.75; P=0.008). Overall, acquisition of HSV-2 was observed in 14 of the susceptible partners who received valacyclovir (1.9 percent), as compared with 27 (3.6 percent) who received placebo (hazard ratio, 0.52; 95 percent confidence interval, 0.27 to 0.99; P=0.04). HSV DNA was detected in samples of genital secretions on 2.9 percent of the days among the HSV-2-infected (source) partners who received valacyclovir, as compared with 10.8 percent of the days among those who received placebo (P<0.001). The mean rates of recurrence were 0.11 per month and 0.40 per month, respectively (P<0.001). CONCLUSIONS: Once-daily suppressive therapy with valacyclovir significantly reduces the risk of transmission of genital herpes among heterosexual, HSV-2-discordant couples.


Asunto(s)
Aciclovir/análogos & derivados , Aciclovir/administración & dosificación , Antivirales/administración & dosificación , Transmisión de Enfermedad Infecciosa/prevención & control , Herpes Genital/tratamiento farmacológico , Herpesvirus Humano 2 , Valina/análogos & derivados , Valina/administración & dosificación , Adolescente , Adulto , Anciano , Esquema de Medicación , Femenino , Herpes Genital/transmisión , Herpesvirus Humano 2/aislamiento & purificación , Herpesvirus Humano 2/fisiología , Humanos , Masculino , Persona de Mediana Edad , Sexo Seguro , Valaciclovir , Activación Viral/efectos de los fármacos
12.
Br J Pharmacol ; 150(4): 502-8, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17211455

RESUMEN

BACKGROUND AND PURPOSE: The neuromedin U (NMU) receptors, NMU1 and NMU2, are expressed in the gut but their functions are unclear. This study explores the role of NMU in gastrointestinal motility. EXPERIMENTAL APPROACH: The effects of NMU were examined in the forestomach and colon isolated from NMU2R wild-type and NMU2R-/- (knockout) mice, looking for changes in muscle tension and in nerve-mediated responses evoked by electrical field stimulation (EFS), and in models of peristalsis in mouse colon and faecal pellet transit in guinea-pig colon. KEY RESULTS: In the mouse forestomach, NMU (1 nM-10 microM) concentration-dependently induced muscle contraction, in the presence of tetrodotoxin and atropine, in preparations from both wild-type and NMU2R-/- mice (pEC50: 7.9, 7.6, Emax: 0.26, 0.20g tension, respectively, n=8 each concentration). The same concentrations of NMU had no consistent effects on the responses to EFS (n=8). In the mouse colon, NMU (0.1 nM-1 microM) had no significant effect on baseline muscle tension (n=8), but concentration-dependently potentiated EFS-evoked contractions in preparations from both wild-type and NMU2R-/- mice, pEC50: 8.1, 7.8, Emax: 24%, 21%, respectively, n=6-11. NMU (0.01 nM-0.1 microM, n=5-7) concentration-dependently decreased the interval between waves of peristalsis in the mouse colon (pEC50: 8.8) and increased the rate at which a faecal pellet moved along the guinea-pig colon. CONCLUSIONS AND IMPLICATIONS: These results demonstrate that NMU exerts colon-specific, nerve-mediated, prokinetic activity, via a pathway involving activation of NMU1 receptors. This suggests that this receptor may represent a molecular target for the treatment of intestinal motility disorders.


Asunto(s)
Colon/fisiología , Sistema Nervioso Entérico/fisiología , Motilidad Gastrointestinal/fisiología , Proteínas de la Membrana/agonistas , Proteínas de la Membrana/fisiología , Neuropéptidos/farmacología , Receptores de Neurotransmisores/agonistas , Receptores de Neurotransmisores/fisiología , Transducción de Señal/fisiología , Animales , Atropina/farmacología , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica , Heces , Cobayas , Técnicas In Vitro , Proteínas de la Membrana/genética , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Antagonistas Muscarínicos/farmacología , Contracción Muscular/fisiología , Peristaltismo/efectos de los fármacos , Receptores de Neurotransmisores/genética , Tetrodotoxina/farmacología
13.
AIDS Patient Care STDS ; 21(8): 575-83, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17711382

RESUMEN

Crystal methamphetamine is a highly addictive stimulant that initially gained popularity in the western region of the United States and has spread to all regions of the country. This study was designed to identify factors associated with methamphetamine use among men who have sex with men (MSM) in North Carolina. Participants were recruited in five gay bars and in five geographically defined Internet chat rooms concurrently in 2005 to complete a brief assessment of drug use and other risk behaviors. Of the 1189 MSM who completed the assessment, mean age was 29 years. Two thirds self-identified as black/African American or other minorities, and 25% as bisexual. Nearly 6% reported using methamphetamines during the past 30 days. In multivariable analysis, MSM who reported using methamphetamines were more likely to report higher education; health insurance coverage; inconsistent condom use during anal sex within the past 3 months; a history of sexually transmitted disease (STD) infection; positive HIV serostatus; and use of medications designed to treat erectile dysfunction. A lack of data exists on methamphetamine use among MSM in the southeastern United States, particularly in nonurban regions. Because the southeastern United States carries a disproportionate HIV, AIDS, and STD burden, our findings underscore the need for further research and intervention.


Asunto(s)
Trastornos Relacionados con Anfetaminas/epidemiología , Homosexualidad Masculina , Internet , Metanfetamina , Trabajo Sexual , Parejas Sexuales , Adolescente , Adulto , Recolección de Datos/métodos , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , North Carolina/epidemiología , Vigilancia de la Población/métodos , Asunción de Riesgos , Conducta Sexual
14.
Clin Microbiol Infect ; 12(5): 463-9, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16643524

RESUMEN

Novel tests (BioPlex) for herpes simplex virus-1 (HSV-1) and HSV-2 IgG were compared with HerpeSelect HSV-1 and HSV-2 ELISAs for type-specific IgG. The sensitivity and specificity of BioPlex HSV-1 IgG were 94% (84/89) and 96% (119/124), respectively, with unselected sera, while the sensitivity and specificity of BioPlex HSV-2 IgG were 92% (109/118) and 98% (95/97), respectively. BioPlex IgM was compared with Diamedix IgM against sera from patients with culture-documented genital herpes. The test results were concordant in 81% of sera from HSV-1 patients and in 90% of sera from HSV-2 patients. Use of BioPlex IgM in addition to BioPlex IgG tests increased HSV-2 seroconversion detection from 47% of subjects to 70%. Use of Diamedix IgM in addition to Focus IgG ELISA increased HSV-2 detection from 40% of subjects to 70%. IgM was detected by BioPlex in 63% of sera from patients with early HSV-2 infection (< 30 days) and in 59% of sera by Diamedix. IgM was also detected in a large proportion of sera from subjects with established HSV-2 infection (33% by BioPlex and 29% by Diamedix). Addition of IgM testing substantially increased the ability to detect seroconversion early in infection. IgM is an indicator of recent infection only in subjects who lack detectable IgG.


Asunto(s)
Anticuerpos Antivirales/sangre , Herpes Genital/sangre , Herpesvirus Humano 1/aislamiento & purificación , Herpesvirus Humano 2/aislamiento & purificación , Inmunoensayo/métodos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Western Blotting , Ensayo de Inmunoadsorción Enzimática , Herpes Genital/inmunología , Herpes Genital/virología , Herpesvirus Humano 1/inmunología , Herpesvirus Humano 2/inmunología , Humanos , Sensibilidad y Especificidad
15.
J Natl Cancer Inst ; 56(3): 479-83, 1976 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-1255780

RESUMEN

An epidemiologic study of 123 patients residing in the Mengo Districts of Uganda, with onset of symptoms of diagnosed Burkitt's lymphoma (BL) in the period 1959-68, revealed a substantial decline in incidence of BL during that decade. Other significant findings included differences by ethnic group in age of patient at onset of BL, a change in the proportions of patients by ethnic group over the decade, a lower incidence rate of BL in the countries of higher altitude, and a seasonal pattern of onset. There was no evidence of the time space clustering previously reported for BL in Uganda. The changing pattern of BL in the Mengo Districts was consistent with the hypothesis that severe malaria infection not only is important in the development of BL but also precipitates onset.


Asunto(s)
Adolescente , Adulto , Factores de Edad , Altitud , Niño , Preescolar , Etnicidad , Femenino , Humanos , Lactante , Malaria/epidemiología , Masculino , Persona de Mediana Edad , Estaciones del Año , Uganda
16.
Cancer Res ; 36(2 pt 2): 667-9, 1976 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-175923

RESUMEN

Infections with both Epstein-Barr virus (EBV) and malaria have been implicated as causal factors in the pathogenesis of Burkitt's lymphoma (BL). Proposed trials of preventive measures for both infections are receiving serious consideration as possible means of establishing a causal relationship with BL. In this paper we examine certain models for the interaction of EBV and malaria in the induction of BL, and also review the aims of the longitudinal, population-based study being conducted in the West Nile District of Uganda. Given existing knowledge, the outcome of preventive trials, even for the most simple interaction models, is unpredictable and, under certain circumstances, trials of an EBV vaccine could actually increase the incidence of BL. It is suggested that trials of an EBV vaccine at this time would be premature and should be delayed at least until the results from the West Nile prospective study are clear.


Asunto(s)
Linfoma de Burkitt/etiología , Herpesvirus Humano 4 , Malaria/complicaciones , Modelos Biológicos , Factores de Edad , Métodos Epidemiológicos , Herpesvirus Humano 4/inmunología , Humanos , Lactante , Malaria/prevención & control , Uganda , Vacunación , Vacunas Virales
17.
Ulster Med J ; 85(1): 13-7, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27158159

RESUMEN

INTRODUCTION: Northern Ireland has high mental health needs and a rising suicide rate. Our area has suffered a 32% reduction of inpatient beds consistent with the national drive towards community based treatment. Taking these factors into account, a new Mental Health Crisis Service was developed incorporating a high fidelity Crisis Response Home Treatment Team (CRHTT), Acute Day Care facility and two inpatient wards. The aim was to provide alternatives to inpatient admission. The new service would facilitate transition between inpatient and community care while decreasing bed occupancy and increasing treatment in the community. METHODS: All services and processes were reviewed to assess deficiencies in current care. There was extensive consultation with internal and external stakeholders and process mapping using the COBRAs framework as a basis for the service improvement model. The project team set the service criteria and reviewed progress. RESULTS: In the original service model, the average inpatient occupancy rate was 106.6%, admission rate was 48 patients per month and total length of stay was 23.4 days. After introducing the inpatient consultant hospital model, the average occupancy rate decreased to 90%, admissions to 43 per month and total length of stay to 22 days. The results further decreased to 83% occupancy, 32 admissions per month and total length of stay 12 days after CRHTT initiation. DISCUSSION: The Crisis Service is still being evaluated but currently the model has provided safe alternatives to inpatient care. Involvement with patients, carers and all multidisciplinary teams is maximised to improve the quality and safety of care. Innovative ideas including structured weekly timetable and regular interface meetings have improved communication and allowed additional time for patient care.


Asunto(s)
Continuidad de la Atención al Paciente/normas , Hospitalización/estadística & datos numéricos , Pacientes Internos/estadística & datos numéricos , Trastornos Mentales/terapia , Servicios de Salud Mental , Salud Mental/estadística & datos numéricos , Humanos , Trastornos Mentales/epidemiología , Servicios de Salud Mental/organización & administración , Servicios de Salud Mental/estadística & datos numéricos , Evaluación de Necesidades , Irlanda del Norte/epidemiología , Evaluación de Procesos y Resultados en Atención de Salud , Mejoramiento de la Calidad
18.
Sci Rep ; 6: 22282, 2016 Feb 29.
Artículo en Inglés | MEDLINE | ID: mdl-26923862

RESUMEN

Epitaxial films of the pyrochlore Nd2Ir2O7 have been grown on (111)-oriented yttria-stabilized zirconia (YSZ) substrates by off-axis sputtering followed by post-growth annealing. X-ray diffraction (XRD) results demonstrate phase-pure epitaxial growth of the pyrochlore films on YSZ. Scanning transmission electron microscopy (STEM) investigation of an Nd2Ir2O7 film with a short post-annealing provides insight into the mechanism for crystallization of Nd2Ir2O7 during the post-annealing process. STEM images reveal clear pyrochlore ordering of Nd and Ir in the films. The epitaxial relationship between the YSZ and Nd2Ir2O7 is observed clearly while some interfacial regions show a thin region with polycrystalline Ir nanocrystals.

19.
J Am Coll Cardiol ; 13(2): 311-5, 1989 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2913109

RESUMEN

Because idiopathic dilated cardiomyopathy is characterized by elevated wall stress and a more spherical left ventricle, the relations among shape, afterload and survival were examined. Thirty-six patients with cardiomyopathy were prospectively studied by two-dimensional echocardiography. Data included echocardiographic short- and long-axis cavity dimensions, their ratio and, with cuff systolic blood pressure, meridional and circumferential end-systolic stress and their ratios. Survivors (n = 16) were followed up for 52 months (range 40 to 76); nonsurvivors (n = 20) died an average of 11 months after study. Survivors had a smaller left ventricular end-diastolic short-axis dimension (6.4 versus 7.1 cm, p less than 0.03) but a similar long-axis length (8.6 versus 8.3 cm). However, overall cavity shape or the ratio of short- to long-axis end-diastolic dimensions was more spherical in those with poorer survival (ratio 0.76 versus 0.68, p less than 0.02). Meridional and circumferential end-systolic stresses were similar in the two groups, but stress was more evenly distributed in the long- and short-axis planes in nonsurvivors (meridional/circumferential stress ratio 0.57 versus 0.52 in survivors, p less than 0.05). Improved survival was associated with an end-diastolic short-axis dimension less than 7.63 cm, a short- to long-axis ratio less than 0.76 and a meridional to circumferential stress ratio less than 0.54. Life table analysis revealed a 28% mortality rate in patients with all three of these characteristics compared with 100% in patients with none. Survivors and nonsurvivors did not differ in systolic cavity dimension, wall thickness, relative wall thickness, cavity volume, percent posterior wall thickening or fractional shortening.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Cardiomiopatía Dilatada/patología , Adolescente , Adulto , Anciano , Cardiomiopatía Dilatada/mortalidad , Ecocardiografía , Femenino , Estudios de Seguimiento , Ventrículos Cardíacos/patología , Humanos , Masculino , Persona de Mediana Edad , Contracción Miocárdica , Pronóstico , Análisis de Regresión , Estrés Mecánico
20.
Arch Intern Med ; 143(1): 161-4, 1983 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-6401419

RESUMEN

Aspergillosis of the cerebral ventricles developed in a 36-year-old heroin abuser who died during the sixth week of illness. The diagnosis was not made during life. A review of our case and of four previous cases from the literature indicates that aspergillosis should be considered in parenteral drug abusers with the syndrome of chronic meningitis or ventriculitis. The diagnosis is difficult to establish, but serologic tests may be helpful. This form of CNS aspergillosis can be cured with antifungal drugs.


Asunto(s)
Aspergilosis/diagnóstico , Ventrículos Cerebrales , Dependencia de Heroína/complicaciones , Adulto , Aspergilosis/microbiología , Aspergillus flavus/aislamiento & purificación , Aspergillus fumigatus/aislamiento & purificación , Encefalopatías/diagnóstico , Encefalopatías/microbiología , Ventrículos Cerebrales/microbiología , Diagnóstico Diferencial , Humanos , Masculino , Meningitis/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA